Waddell & Associates’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$718K Sell
1,356
-95
-7% -$43.8K 0.04% 185
2026
Q1
$697K Sell
1,451
-4
-0.3% -$2.05K 0.04% 157
2025
Q4
$817K Buy
1,455
+560
+63% +$318K 0.06% 110
2025
Q3
$460K Buy
+895
New +$391K 0.04% 148

Other funds holding MEDP

Waddell & Associates's MEDP Position: Q2 2026 in Review

Waddell & Associates reduced its Medpace (MEDP) stake by 6.5% in Q2 2026, selling an estimated $43.8K and leaving 1,356 shares worth $718K. The position accounts for 0.04% of the portfolio, ranked #185.

Waddell & Associates first reported a position in MEDP in Q3 2025 and has held it in 4 quarters since. The position peaked at $817K in Q4 2025. 121 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Waddell & Associates held 1,356 shares of Medpace worth $718K as of Q2 2026.
  • Waddell & Associates sold 95 Medpace shares in Q2 2026, an estimated $43.8K.
  • Medpace made up 0.04% of Waddell & Associates's portfolio in Q2 2026, its #185 holding.
  • Waddell & Associates first reported a position in Medpace in Q3 2025 and has held it in 4 quarters since.
  • Waddell & Associates's Medpace position peaked at $817K in Q4 2025.
  • 121 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Waddell & Associates's 13F filing for Q2 2026, filed 15 Jul 2026.